13F

Stock

Traws Pharma, Inc.

TRAW · held by 23 managers

Reported value

$3.86M

Holders

23

+0 new · −1 exited

Holders’ est. mark

−$73

Price effect on 1 books still in the name

Largest holder

$824.9K

ADAGE CAPITAL PARTNERS GP, L.L.C.

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
ADAGE CAPITAL PARTNERS GP, L.L.C.730K$824.9KHeld
Squadron Capital Management LLC713.5K$806.3KHeld
Ikarian Capital, LLC678.1K$766.3KHeld
ORBIMED ADVISORS LLC605.5K$684.3KHeld
BOOTHBAY FUND MANAGEMENT, LLC194.5K$219.8KHeld
ADAR1 Capital Management, LLC154.4K$174.5KHeld
Vanguard87.3K$98.6KHeld
GEODE CAPITAL MANAGEMENT, LLC61.7K$69.7KHeld
Seven Fleet Capital Management LP49.3K$55.7KHeld
XTX Topco Ltd42.2K$47.7KHeld
State Street25.8K$29.2KHeld
Citadel24.8K$28KHeld
TWO SIGMA INVESTMENTS, LP19.2K$21.7KHeld
SUSQUEHANNA INTERNATIONAL GROUP, LLP14.2K$16KHeld
BlackRock, Inc.9.96K$11.3KHeld
UBS Group AG7.72K$8.73KHeld
SBI Securities Co., Ltd.162$183Held
BANK OF AMERICA CORP /DE/113$128−$73Cut−$61
OSAIC HOLDINGS, INC.8$9Held
Fidelity2$2Held
CITIGROUP INC1$1Held
Motiv8 Investments LLC13$0Held
Cygnus Capital Advisors, LLC1.92K$0Held

Who left

Positions as of Q4 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.